These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4898101)

  • 1. In vivo and in vitro chelation of plutonium by alpha-lipoic acid and DTPA. BNWL-714.
    Dilley JV
    BNWL Rep; 1968 May; ():6.12-6+. PubMed ID: 4898101
    [No Abstract]   [Full Text] [Related]  

  • 2. Plutonium-contaminated wound studies. BNWL-714.
    McClanahan BJ
    BNWL Rep; 1968 May; ():6.3-6+. PubMed ID: 5307100
    [No Abstract]   [Full Text] [Related]  

  • 3. Dependency of chelation efficacy upon time after first DTPA injection.
    Lloyd RD; Taylor GN; Mays CW; Jones CW; Bruenger FW; Atherton DR
    Radiat Res; 1979 Jun; 78(3):448-54. PubMed ID: 451166
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined effect of DTPA and citrate on an intramuscular 239Pu deposit in rats.
    Volf V
    Health Phys; 1974 Jul; 27(1):152-3. PubMed ID: 4430623
    [No Abstract]   [Full Text] [Related]  

  • 5. Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I.
    Guilmette RA; Moretti ES; Lindenbaum A
    Radiat Res; 1979 Jun; 78(3):415-28. PubMed ID: 221958
    [No Abstract]   [Full Text] [Related]  

  • 6. Removal of inhaled 239PuF4 in beagles. BNWL-714.
    Dilley JV; McDonald KE
    BNWL Rep; 1968 May; ():6.11. PubMed ID: 5306301
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of DTPA therapy on long-term effects of retained monomeric plutonium: comparison with polymeric plutonium.
    Osenthal MW; Lindenbaum A
    Radiat Res; 1967 Jul; 31(3):506-21. PubMed ID: 6027890
    [No Abstract]   [Full Text] [Related]  

  • 8. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ascorbate ions in DTPA treatment after contamination by mixed plutonium dioxide-sodium burning products.
    Métvier H; Masse R; Nolibé D; Nénot JC; Lafuma J
    Health Phys; 1977 May; 32(5):450-2. PubMed ID: 881345
    [No Abstract]   [Full Text] [Related]  

  • 10. Removal of plutonium from beagles using Ca-DTPA and Zn-DTPA: effects on initial DTPA injection.
    Taylor GN; Lloyd RD; Boseman JJ; Atherton DR; Mays CW
    Health Phys; 1978 Aug; 35(2):201-10. PubMed ID: 701016
    [No Abstract]   [Full Text] [Related]  

  • 11. Decorporation from beagles of a mixture of monomeric and particulate plutonium using Ca-DTPA and Zn-DTPA: dependence upon frequency of administration.
    Lloyd RD; Boseman JJ; Taylor GN; Bruenger FW; Atherton DR; Stevens W; Mays CW
    Health Phys; 1978 Aug; 35(2):217-27. PubMed ID: 701018
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of pentacin (DTPA) in deposition of Ce144 in lung tissue].
    Borisov VP; Korolev GK
    Med Radiol (Mosk); 1967 Feb; 12(2):79-81. PubMed ID: 5616164
    [No Abstract]   [Full Text] [Related]  

  • 13. Action of DTPA on hepatic plutonium. III. Evidence for a direct chelation mechanism for DTPA-induced excretion of monomeric plutonium into rat bile.
    Bhattacharyya MH; Peterson DP
    Radiat Res; 1979 Oct; 80(1):108-15. PubMed ID: 504565
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental studies of the use of DTPA and other agents to limit the systemic burden of plutonium after wound contamination.
    Harrison JD; David AJ
    Radiat Res; 1979 Mar; 77(3):534-46. PubMed ID: 441257
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of standard Licam (C) in plutonium radiocontamination].
    Gerasimo P; Duserre C; Ducousso R; Metivier H
    Ann Pharm Fr; 1987; 45(3):189-94. PubMed ID: 3434970
    [No Abstract]   [Full Text] [Related]  

  • 16. DTPA therapy for chelation of 239 Pu in bone: the influence of bone remodelling.
    James AC; Taylor DM
    Health Phys; 1971 Jul; 21(1):31-9. PubMed ID: 5114657
    [No Abstract]   [Full Text] [Related]  

  • 17. [Research in the complexon series. I. Detoxicant capacity of Ca-DTPA in experimental chronic plutonium poisoning in rats. II. Influence of the repeated intravenous administration of Ca-DTPA on the elimination of trace elements in rats. 3. Preliminary results of the study, in rats, of the modalities of calcium elimination after Ca45-DTPA injection].
    Truhaut R; Boudène C; Lutz M
    Ann Biol Clin (Paris); 1966; 24(3):419-39. PubMed ID: 5932716
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of DTPA and calcium on intraperitoneally injected 239PuO2 particles. BNWL-714.
    Sanders CL; Bair WJ
    BNWL Rep; 1968 May; ():6.17-6+. PubMed ID: 5307098
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Zn-DTPA in removing plutonium from the human body.
    Ohlenschläger L
    Health Phys; 1976 Feb; 30(2):249-50. PubMed ID: 1245431
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of phagocytosis and the effect of different DTPA salts on the mechanism of lung self-purification of 239Pu].
    Levdik TI; Osobets SV
    Med Radiol (Mosk); 1980 Oct; 25(10):44-8. PubMed ID: 7421452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.